At the end of the latest market close, Miragen Therapeutics Inc. (MGEN) was valued at $0.94. In that particular session, Stock kicked-off at the price of $0.94 while reaching the peak value of $0.94 and lowest value recorded on the day was $0.9001. The stock current value is $0.83.
Recently in News on September 14, 2020, miRagen Announces Leadership Transition and Review of Strategic Alternatives. Lee Rauch appointed President and CEO, following resignation by William Marshall. You can read further details here
Miragen Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.2700 on 01/30/20, with the lowest value was $0.3110 for the same time period, recorded on 03/19/20.
Miragen Therapeutics Inc. (MGEN) full year performance was -4.09%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Miragen Therapeutics Inc. shares are logging -63.61% during the 52-week period from high price, and 165.63% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.31 and $2.27.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1026879 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Miragen Therapeutics Inc. (MGEN) recorded performance in the market was 95.87%, having the revenues showcasing -6.93% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 53.88M, as it employees total of 45 workers.
Analysts verdict on Miragen Therapeutics Inc. (MGEN)
During the last month, 4 analysts gave the Miragen Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.9455, with a change in the price was noted +0.2774. In a similar fashion, Miragen Therapeutics Inc. posted a movement of +49.54% for the period of last 100 days, recording 2,240,616 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for MGEN is recording 0.42 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.25.
Miragen Therapeutics Inc. (MGEN): Technical Analysis
Raw Stochastic average of Miragen Therapeutics Inc. in the period of last 50 days is set at 5.78%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 10.36%. In the last 20 days, the company’s Stochastic %K was 19.44% and its Stochastic %D was recorded 21.52%.
Let’s take a glance in the erstwhile performances of Miragen Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 95.87%. Additionally, trading for the stock in the period of the last six months notably improved by 123.70%, alongside a downfall of -4.09% for the period of the last 12 months. The shares increased approximately by 4.40% in the 7-day charts and went up by -16.07% in the period of the last 30 days. Common stock shares were lifted by -6.93% during last recorded quarter.